AIIMS - The Purbottar

24 Jun

AIIMS chief Randeep Guleria on talking about Covid vaccine for children likely by September-October

editor0 CommentsCovid-19, Health, IndiaAIIMS, covid, Randeep Guleria

AIIMS Director, Dr Randeep Guleria said that we are hoping that by October India will have its own vaccine for children. It has been found that kids usually have mild symptoms of coronavirus. Guleria said that we are hopeful vaccine trial will be completed early and we will get the data by september. Hopefully, by that time, approvals will be there so that by September-October we'll have vaccines from our country. Bharat Biotech & other companies are doing trials at a very fast pace as parents have come forward with their children,while Pfizer has already got the FDA approval for…

Delta variant of Covid-19 can infect Covishield Or Covaxin vaccinated people, claims AIIMS study

editor0 CommentsHealthAIIMS, Covid19, Delta Varient

The National Centre for Disease Control (NCDC) and All India Institute of Medical Science (AIIMS) in collaboration with the Institute of Genomics and Integrative Biology (IGIB) have done two separate studies which have shown that the Delta variant of COVID-19 can infect people who have received one or two jabs of either Covishield or Covaxin. In the AIIMS-IGIB study, no death has been reported in the 63 subjects, but the study has found out that the Delta variant is predominant in the reinfection cases. All of them got breakthrough infections and among the samples which were genome sequenced, the Delta variant…

‘Covaxin’ Human Trial Process Begins at Hyderabad’s NIMS, Patna AIIMS

editor0 CommentsHealthAIIMS, Covid-19, NIMS

Now that India has developed its first indigenous COVID-19 vaccine, Covaxin, it has started its preparations to begin the much-awaited human clinical trials. Covaxin will be tested on more than 1100 people. The vaccine developed by the Bharat Biotech recently got the green signal from ICMR and the apex body has given nod to a total of 12 hospitals to begin preparations to conduct human clinical trials. Two of them include Hyderabad’s Nizam’s Institute of Medical Sciences and Patna-based All India Institute of Medical Science (AIIMS) As per reports, the human trial will take at least 6 to 8 months to…